On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Avera Health

InstitutionResearch output, impact & collaborations

Avera Health is a institution indexed in ScholarIQ from OpenAlex.

What is known about Avera Health?

ScholarIQrecord summary

Avera Health is a research organisation in Sioux Falls, US. OpenAlex records 1,378 works and 65,670 citations for it. 420 researchers list it as their most recent affiliation.

How many works does Avera Health have?

ScholarIQindexed works

Avera Health has 1,378 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Avera Health have?

ScholarIQcitation count

Avera Health has 65,670 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Avera Health?

ScholarIQresearcher count

Avera Health has 420 researchers in the ScholarIQ index.

What is the average h-index at Avera Health?

ScholarIQavg h-index

Avera Health has an average h-index of 65 in OpenAlex.

What is the ROR of Avera Health?

ScholarIQror

The ROR for Avera Health is on the source record.

What is the OpenAlex record for Avera Health?

ScholarIQopenalex

The OpenAlex for Avera Health is on the source record.

What is the Wikidata of Avera Health?

ScholarIQwikidata

The Wikidata for Avera Health is on the source record.

Who are the most-cited researchers behind Avera Health?

ScholarIQtop researchers by citations
1
Brian Leyland‐Jones · HER2/EGFR in Cancer Research
440 works32,403 citations

What are the most-cited papers on Avera Health?

ScholarIQmost cited works
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak, H. Fuchs, Virginia Paton, Alex Bajamonde, Thomas Fleming, W. Eiermann, Janet Wolter, Mark D. Pegram, José Baselga, Larry Norton
New England Journal of Medicine. 200111,555 CitationsOPEN ACCESS
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, José Baselga, Richard H. Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun‐Sheng Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas Suter, Josef Rüschoff, Tamás Sütö, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, Mirko Dolci, Richard D. Gelber
New England Journal of Medicine. 20055,111 CitationsOPEN ACCESS
Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer
Douglas Yee, Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain, Yunn-Yi Chen, Gregor Krings, Shi Wei, Shuko Harada, Brian Datnow, Oluwole Fadare, Molly Klein, Stefan E. Pambuccian, Beiyun Chen, Kathi Adamson, Sharon B. Sams, Paulette Mhawech‐Fauceglia, Anthony M. Magliocco, Mike Feldman, Mara H. Rendi, Husain Sattar, Jay Zeck, Idris Tolgay Ocal, Ossama Tawfik, Lauren LeBeau, Sunati Sahoo, Tuyethoa N. Vinh, A. Jo Chien, Andres Forero‐Torres, Erica Stringer-Reasor, Anne M. Wallace, Lajos Pusztai, Judy C. Boughey, Erin D. Ellis, Anthony Elias, Janice Lu, Julie E. Lang, Hyo S. Han, Amy S. Clark, Rita Nanda, Donald W. Northfelt, Qamar J. Khan, Rebecca K. Viscusi, David Euhus, Kirsten K. Edmiston, Jane Yuet Ching Hui, Kathleen Kemmer, John W. Park, Minetta C. Liu, Olufunmilayo I. Olopade, Brian Leyland‐Jones, Debasish Tripathy, Stacy L. Moulder, Hope S. Rugo, Richard B. Schwab, Shelly S. Lo, Teresa Helsten, Heather Beckwith, Patricia Haugen, Nola M. Hylton, Laura J. van’t Veer, Jane Perlmutter, Michelle Melisko, Amy Wilson, Garry Peterson, Adam L. Asare, Meredith Buxton, Melissa Paoloni, Julia L. Clennell, Gillian L. Hirst, Ruby Singhrao, Katherine Steeg, Jeffrey B. Matthews, Smita Asare, Ashish Sanil, Scott Berry, Laura J. Esserman, Donald A. Berry
JAMA Oncology. 2020227 CitationsOPEN ACCESS

How much of the research on Avera Health is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
25%
Hybrid
0%
Bronze
75%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial